Literature DB >> 23211694

The other side of abnormal: a case series of low transcranial Doppler velocities associated with stroke in children with sickle cell disease.

Iris D Buchanan1, Anne James-Herry, Ifeyinwa Osunkwo.   

Abstract

The prevalence of cerebrovascular events in sickle cell disease (SCD) can be as low as 10% by the age of 18 for overt cerebral infarction or strokes, up to 35% for silent cerebral infarction, and as high as 43/100 patient years for acute silent cerebral ischemic events. These events typically occur during childhood with a peak incidence between the age of 4 and 7 years. The cumulative risk of central nervous system events in SCD increases with age. Transcranial Doppler (TCD) ultrasonography is an established screening tool for detecting children with SCD at highest risk for stroke by measuring the flow velocity in the large intracranial vessels. Velocities are considered abnormal with readings >200 cm/s and chronic red cell transfusions are recommended to reduce further risk or progression. Red cell transfusions have reduced the rate of cerebrovascular accidents by 90%. We describe the case of 5 children with sickle cell anemia, whose antecedent screening TCD velocities were measured to be ≤70 cm/s in the study. All patients developed some form of cerebral insults, an overt cerebral infarctions, silent stroke or transient ischemic attack, and are now receiving chronic transfusion to prevent further progression. On the basis of these cases, low TCD velocities may identify another group of children at risk for cerebrovascular disease. We suggest TCD velocities <70 cm/s in major vessels (MCA, ACA, and ICA) be considered another type of "abnormal," prompting more sensitive evaluations (such as a brain MRI and MRA) for the presence of central nervous system disease, and, if negative, decrease intervals between subsequent TCD assessments.

Entities:  

Mesh:

Year:  2013        PMID: 23211694     DOI: 10.1097/MPH.0b013e318279caae

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  8 in total

Review 1.  Advances in Understanding Ischemic Stroke Physiology and the Impact of Vasculopathy in Children With Sickle Cell Disease.

Authors:  Kristin P Guilliams; Melanie E Fields; Michael M Dowling
Journal:  Stroke       Date:  2019-02       Impact factor: 7.914

Review 2.  Neuroimaging findings in sickle cell disease.

Authors:  S C Thust; C Burke; A Siddiqui
Journal:  Br J Radiol       Date:  2014-05-21       Impact factor: 3.039

3.  Sickle cell anemia: reference values of cerebral blood flow determined by continuous arterial spin labeling MRI.

Authors:  M Arkuszewski; J Krejza; R Chen; E R Melhem
Journal:  Neuroradiol J       Date:  2013-05-10

4.  Asymmetric Dimethylarginine Levels and Its Correlation to Cerebral Blood Flow in Children with Sickle Cell Anemia.

Authors:  Mohamed El-Shanshory; Nahed Hablas; Hala Nagy; Naglaa Fathy
Journal:  Indian J Hematol Blood Transfus       Date:  2019-03-13       Impact factor: 0.900

Review 5.  Small molecule inhibitors in the treatment of cerebral ischemia.

Authors:  Jerry J Flores; Yang Zhang; Damon W Klebe; Tim Lekic; Weiling Fu; John H Zhang
Journal:  Expert Opin Pharmacother       Date:  2014-02-04       Impact factor: 3.889

6.  Transcranial Doppler and Magnetic Resonance in Tanzanian Children With Sickle Cell Disease.

Authors:  Edward N Kija; Dawn E Saunders; Emmanuel Munubhi; Angela Darekar; Simon Barker; Timothy C S Cox; Mechris Mango; Deogratias Soka; Joyce Komba; Deogratias A Nkya; Sharon E Cox; Fenella J Kirkham; Charles R J C Newton
Journal:  Stroke       Date:  2019-06-14       Impact factor: 7.914

7.  Association of laboratory markers and cerebral blood flow among sickle cell anemia children.

Authors:  Corynne Stéphanie Ahouéfa Adanho; Sètondji Cocou Modeste Alexandre Yahouédéhou; Sânzio Silva Santana; Camilo Vieira; Rayra Pereira Santiago; Jeanne Machado de Santana; Thassila Nogueira Pitanga; Milena Magalhães Aleluia; Vítor Valério Maffili; Ivana Paula Ribeiro Leite; Dalila Luciola Zanette; Isa Menezes Lyra; Marilda Souza Goncalves
Journal:  Front Pediatr       Date:  2022-08-26       Impact factor: 3.569

8.  Haptoglobin, alpha-thalassaemia and glucose-6-phosphate dehydrogenase polymorphisms and risk of abnormal transcranial Doppler among patients with sickle cell anaemia in Tanzania.

Authors:  Sharon E Cox; Julie Makani; Deogratias Soka; Veline S L'Esperence; Edward Kija; Paula Dominguez-Salas; Charles R J Newton; Anthony A Birch; Andrew M Prentice; Fenella J Kirkham
Journal:  Br J Haematol       Date:  2014-02-21       Impact factor: 6.998

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.